At the threshold between electricity and chemistry in the human brain, a small protein interaction has long governed whether signals live or die — yet its precise mechanics remained unknown. Researchers at DGIST in South Korea have now identified a molecular lever, a pivot point called R370, that physically reshapes calcium channels based on which proteins bind to them, controlling how long calcium can flow and how faithfully neurons communicate. The discovery, published in the Proceedings of the National Academy of Sciences in July 2026, answers a question neuroscience has carried for decades
Researchers identify 'molecular lever' mechanism controlling brain calcium channels
a molecular lever that controls how long calcium can flow through
Mark
Why does it matter that we now understand how this lever works? Couldn't drugs already target calcium channels?
Mimi
They could, but blindly. Imagine trying to adjust a door hinge without knowing it was a hinge—you might wedge something in, but you can't fine-tune it. Now we know the actual mechanism, so we can design drugs that work with it rather than against it.
Mark
So this is about precision rather than discovery of something entirely new?
Mimi
Exactly. The channel existed. Drugs existed. But we were treating it like a black box. Now we can see inside.
Mark
How long has this question been open?
Mimi
Long enough that it's called a "long-standing question" in the field. This is the kind of thing that's been nagging at neuroscientists for years—obvious enough to notice, but hidden enough to resist explanation.
Mark
Does this discovery immediately lead to new drugs?
Mimi
Not immediately. It's foundational. It gives drug developers a target and a mechanism to aim at. The actual drugs will take years to develop and test. But without this map, they'd still be working in the dark.
Mark
Which brain disorders stand to benefit most?
Mimi
The ones where calcium signaling is clearly broken—epilepsy, neuropathic pain, autism spectrum disorder, Alzheimer's. But there may be others we don't yet recognize as calcium-channel problems.
Mark
Why was this so hard to figure out before?
Mimi
The lever is tiny, and it only moves when the auxiliary protein binds. You need the right tools to see it, the right way to measure it, and the right intuition to recognize what you're looking at. This team had all three.
Le Pouls
- Calcium channels sit at the very hinge of neural communication, and their malfunction underlies some of the most stubborn and devastating brain disorders known to medicine.
- For decades, scientists knew beta subunit proteins altered how long these channels stayed open, but the physical reason why remained an unsolved puzzle — a gap that limited drug design to blunt, imprecise interventions.
- Professor Byung Chang Suh's team at DGIST identified a single structural point, R370, that acts as a lever: as different beta subunits attach, the surrounding loop rotates around this pivot, physically reshaping the channel and governing calcium flow.
- Electrophysiological recordings and mathematical modeling confirmed the mechanism is not theoretical — it is the actual engine driving signal timing in living neurons.
- The discovery reframes drug development for conditions like epilepsy and Alzheimer's, offering researchers a precise molecular target rather than a crude on-off switch for calcium channel activity.
At the threshold between electricity and chemistry in the human brain, a small protein interaction has long governed whether signals live or die — yet its precise mechanics remained unknown. Researchers at DGIST in South Korea have now identified a molecular lever, a pivot point called R370, that physically reshapes calcium channels based on which proteins bind to them, controlling how long calcium can flow and how faithfully neurons communicate. The discovery, published in the Proceedings of the National Academy of Sciences in July 2026, answers a question neuroscience has carried for decades — and in doing so, opens a more precise path toward treating epilepsy, neuropathic pain, autism, and Alzheimer's disease.
Inside every neuron, information travels as electricity until it reaches a gap — and there, the cell must convert that pulse into chemistry, flooding calcium ions inward through tiny membrane channels. Whether a signal reaches the next neuron or dissolves depends on how long those channels stay open. For decades, scientists knew that auxiliary proteins called beta subunits influenced this timing, but the physical mechanism behind it remained out of reach.
A team at DGIST, led by Professor Byung Chang Suh and including graduate student Jin-Nyung Woo and researcher Jeongeun Kim, has now resolved that mystery. Through careful structural analysis of the CaV2.2 calcium channel — the gatekeeper between electrical and chemical signaling — they found that a specific point labeled R370 sits at an unusual angle at the start of a region called the I–II loop. When different beta subunits bind to the channel, this loop rotates around R370 like a lever, shifting the channel's overall shape and controlling how long calcium can flow through.
The team validated the model using electrophysiological recordings of individual channels and mathematical modeling to track how structural changes affected signal timing. The data confirmed that this mechanical pivot is not an abstraction — it is the actual means by which neurons regulate their own communication.
The implications reach across some of neurology's most resistant conditions. Epilepsy, neuropathic pain, autism spectrum disorder, and Alzheimer's disease all involve disrupted calcium signaling. By mapping the precise lever that governs these channels, the researchers have handed drug developers a far more refined target — one that could enable therapies tuned to adjust calcium flow with new specificity, rather than simply blocking or opening channels wholesale. What began as a fundamental question about molecular mechanics may now shorten the distance to treatments that have long eluded conventional approaches.
Inside a neuron, information travels as electricity until it reaches a gap. There, the cell must convert that electrical pulse into chemistry—a cascade of calcium ions flooding inward through tiny channels in the cell membrane. What happens next determines whether a signal gets through to the next neuron or dies. For decades, neuroscientists understood that calcium channels open and close, but they could not explain the precise mechanical reason why.
A research team at DGIST, led by Professor Byung Chang Suh in the Department of Brain Sciences, has now answered that question. Working with graduate student Jin-Nyung Woo and researcher Jeongeun Kim, they identified what amounts to a molecular lever—a physical mechanism that controls how long these channels stay open. The discovery, published in the July 2026 issue of the Proceedings of the National Academy of Sciences, reveals how auxiliary proteins called beta subunits reshape the calcium channel itself, like a hand adjusting the angle of a door hinge.
The calcium channel in question is known as CaV2.2, or N-type voltage-gated calcium channel. It sits at the boundary between electrical and chemical signaling in the brain. When a beta subunit attaches to this channel, it changes how long the channel remains open—but the mechanism behind that change had remained mysterious. The team's breakthrough came through careful structural analysis. They found that a specific point on the channel, labeled R370 and located at the start of a region called the I–II loop, was bent at an unusual angle. This bent region acts as a pivot point. As different types of beta subunits bind to the channel, the loop rotates around R370 like a lever, shifting the channel's overall shape and, in turn, controlling how long calcium can flow through.
To confirm this model was not merely theoretical, the researchers measured the channel's behavior using electrophysiological techniques—essentially recording the electrical activity of individual channels—and applied mathematical modeling to track how the structural changes affected the timing of the channel's opening and closing. The data confirmed that these mechanical shifts are essential to how neurons actually transmit signals.
The implications extend far beyond basic science. Calcium channels malfunction in a range of neurological conditions. Epilepsy, neuropathic pain, autism spectrum disorder, and Alzheimer's disease all involve disrupted calcium signaling. By revealing the precise mechanism that controls these channels, the team has provided a blueprint for drug developers. Rather than designing medications that simply block or activate channels in crude fashion, researchers can now target the molecular lever itself—potentially creating therapies that fine-tune calcium flow with unprecedented precision.
Professor Suh noted in a statement that the discovery resolves a question that had persisted in neuroscience for years: how exactly do beta subunits induce the dynamic structural changes that regulate calcium channels. The work was supported by multiple programs of South Korea's National Research Foundation. What began as a fundamental question about molecular mechanics may now accelerate the development of treatments for conditions that have resisted conventional approaches.
Citations marquantes
We clearly elucidated the long-standing question of how beta-subunit binding induces dynamic and structural changes in calcium channels. We expect the newly discovered molecular-lever mechanism to greatly contribute to the future development of new therapeutics for brain disorders.— Professor Byung Chang Suh, Department of Brain Sciences, DGIST
Envie de l'histoire complète ?
Lire l'original sur News-Medical ↗
Health & Medicine